Home > Insider Trading > Filing (0001140361-17-046077)

Filing Details

Accession Number:: 0001140361-17-046077
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-13 17:28:11
Reporting Period:: 2017-12-11

Accepted Time:: 2017-12-13 17:28:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
357097	Fibrocell Science Inc.	FCSC	Pharmaceutical Preparations (2834)	870458888

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1091823	J Randal Kirk	C/O Third Security, Llc 1881 Grove Avenue Radford VA 24141		No	No	Yes	No
1356090	Intrexon Corp	C/O Legal Department 20374 Seneca Meadows Parkway Germantown MD 20876		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-11	2,567,121	$0.77	5,773,626	No	4	P	Indirect	by NRM VII Holdings
Common Stock	Acquisiton	2017-12-11	155,347	$0.77	349,386	No	4	P	Indirect	by Kapital Joe
Common Stock	Acquisiton	2017-12-11	4,805	$0.77	10,806	No	4	P	Indirect	by Mascara Kaboom

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by NRM VII Holdings
No	4	P	Indirect	by Kapital Joe
No	4	P	Indirect	by Mascara Kaboom

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2017-12-11	2,567,121	$0.00	2,567,121	$0.77
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2017-12-11	155,347	$0.00	155,347	$0.77
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2017-12-11	4,805	$0.00	4,805	$0.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,567,121	2017-12-11	2022-12-11	No	4	P	Indirect
155,347	2017-12-11	2022-12-11	No	4	P	Indirect
4,805	2017-12-11	2022-12-11	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,133,595	Indirect	by Intrexon

Footnotes

The indicated number of common shares is reflective of a 1-for-3 reverse stock split effected by the issuer on March 13, 2017.
Randal J. Kirk controls Kapital Joe, LLC ("Kapital Joe"), Mascara Kaboom, LLC ("Mascara Kaboom") and NRM VII Holdings I, LLC ("NRM VII Holdings"). Shares held by these entities may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Randal J. Kirk, directly and through certain affiliates, is the largest shareholder of Intrexon Corporation ("Intrexon") and serves as Intrexon's Chairman of the Board and Chief Executive Officer. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon. Shares held by Intrexon may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
The indicated number of warrants to purchase common stock of the issuer were received in connection with the purchase of common stock in an underwritten public offering of the issuer, which closed on December 11, 2017 (the "Offering"). In the Offering, each share of common stock was sold together with a common warrant to purchase one share of common stock at a combined effective price of $0.77 per share and accompanying common warrant.